New guidelines for standardizing glucose reporting and optimizing clinical decision making in diabetes

March 1, 2013 in Diabetes

New guidelines for standardizing glucose reporting and optimizing clinical decision making in diabetes

Enlarge

©2013 Mary Ann Liebert, Inc., publishers

Most adults and children with type 1 diabetes are not in optimal glycemic control, despite advances in insulin formulations and delivery systems and glucose monitoring approaches. Critical barriers to optimal glycemic control remain. A panel of experts in diabetes management and research met to explore these challenges, and their conclusions and recommendations for how to improve care and optimize clinical decision-making are presented in a white paper in Diabetes Technology & Therapeutics (DTT).

Lead author Richard Bergenstal, MD, International Diabetes Center at Park Nicollet (IDC), outlines the critical issues impacting diabetes management as identified by the panel of luminaries in the field of diabetes during meetings facilitated by the IDC and funded by the Helmsley Charitable Trust. The team of authors emphasizes the critical need for standardization in the collection, reporting, visualization, and analysis of glucose monitoring data, and proposes clear and practical recommendations for implementing these solutions.

The expert panel included DTT Editor-in-Chief Satish Garg, MD, DTT Senior Editor Irl Hirsch, MD, and Andrew Ahmann, MD, Timothy Bailey, MD, Roy Beck, MD, PhD, Joan Bissen, Bruce Buckingham, MD, Larry Deeb, MD, Robert Dolin, MD, Robin Goland, MD, David Klonoff, MD, Davida Kruger, MSN, Glenn Matfin, MB ChB, MSc, Roger Mazze, PhD, Beth Olson, BAN, RN, Christopher Parkin, MS, Anne Peters, MD, Margaret Powers, PhD, Henry Rodriguez, MD, Phil Southerland, Ellie Strock, ANP-BC, William Tamborlane, MD, and David Wesley.

" is an essential part of effective , and although it has come a long way, both health care providers and patients are frustrated that glucose data reporting has not been standardized," says Satish Garg, MD, Editor-in-Chief of the Journal and Professor of Medicine and Pediatrics at the University of Colorado Denver. "The recommendations reported in this white paper are a good first step toward improving health care outcomes in ."

The white paper is accompanied by three Commentaries: one by DTT Editor-in-Chief Satish Garg, MD, one by Francine Ratner Kaufman, MD, Medtronic and Children's Hospital, Los Angeles, and one by Aaron Kowalski, PhD and Sanjoy Dutta, PhD, Juvenile Diabetes Research Foundation.

More information: The paper is available free on the Diabetes Technology & Therapeutics website at http://www.liebertpub.com/dia.

Provided by Mary Ann Liebert, Inc search and more info website

not rated yet  

Rank not rated yet
Relevant PhysicsForums posts

More news stories

Study shows that women who smoke during pregnancy increase the risk of both obesity and gestational diabetes in their da

Women who smoke during pregnancy increase the risk of both obesity and gestational diabetes, in their daughters, concludes research published in Diabetologia, the journal of the European Association for the Study of Diabet ...

Diabetes created May 20, 2013 | popularity not rated yet | comments 0

Rise in type 2 diabetes amongst young

The number of young people diagnosed with type 2 diabetes has seen the sharpest rise over the last twenty years compared to a background of a general increase across the board, new University research has ...

Diabetes created May 20, 2013 | popularity not rated yet | comments 0

Research uncovers a potential role of two proteins in diabetes

(Medical Xpress)—Flinders University researchers are breaking new ground in a decade-long journey to pinpoint the function of two closely related proteins.

Diabetes created May 20, 2013 | popularity 5 / 5 (2) | comments 0 | with audio podcast

Exercise prevents fructose-induced hypertriglyceridemia

(HealthDay)—Moderate aerobic exercise prevents fructose-induced hypertriglyceridemia in healthy males, according to a study published online May 14 in Diabetes.

Diabetes created May 17, 2013 | popularity 5 / 5 (1) | comments 0 | with audio podcast

DNA variant affects diabetes risk and treatment response

A DNA variant near a digestive enzyme does not only affect risk of developing diabetes but also affects the response to treatment, an international consortium of researchers including the University of Dundee has found.

Diabetes created May 17, 2013 | popularity not rated yet | comments 0 | with audio podcast


If you can remember it, you can remember it wrong

(Medical Xpress)—Native peoples in regions where cameras are uncommon sometimes react with caution when their picture is taken. The fear that something must have been stolen from them to create the photo ...

B vitamins could delay dementia

(Medical Xpress)—Despite spending billions of dollars on research and development, drug companies have been unable to come up with effective treatments for dementia and Alzheimer's Disease (AD). Now, A. ...

Insight into the dazzling impact of insulin in cells

Australian scientists have charted the path of insulin action in cells in precise detail like never before. This provides a comprehensive blueprint for understanding what goes wrong in diabetes.

New sleeping pill poised to hit US markets

An experimental sleeping pill from US drug company Merck is effective at helping people fall and stay asleep, according to reviewers at the US Food and Drug Administration, which could soon approve the new drug.

Reducing caloric intake delays nerve cell loss

Activating an enzyme known to play a role in the anti-aging benefits of calorie restriction delays the loss of brain cells and preserves cognitive function in mice, according to a study published in the May ...

Antidepressant reduces stress-induced heart condition

A drug commonly used to treat depression and anxiety may improve a stress-related heart condition in people with stable coronary heart disease, according to researchers at Duke Medicine.